Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT07387224
Active, not recruiting Observational

Identification of Patients With Advanced Chronic Diseases in Need of Palliative Care

NCT07387224 · tracked via the Priya Life Science Spain tracker
Sponsor
Infanta Leonor University Hospital
Phase
Observational
Started
2024-02-01
Last updated
2026-06-10

Condition(s) studied

CancerChronic Liver Disease (CLD)Heart Failure ChronicChronic Kidney Disease (Stages 4 and 5)

Study summary

Patients with advanced chronic diseases often have complex health needs and may benefit from palliative care. However, many of these patients are not identified early enough to receive appropriate palliative care interventions.

This prospective observational study aims to identify hospitalized patients and patients attending a day hospital with advanced chronic conditions who have palliative care needs, using the NECPAL tool. NECPAL is a validated screening instrument designed to identify patients with advanced chronic diseases who may benefit from palliative care, based on clinical indicators, disease progression, functional decline, and health care utilization.

Adult patients with advanced oncological and non-oncological chronic diseases will be consecutively evaluated. The NECPAL tool will be applied by trained investigators as part of routine clinical assessment. Patients will be classified as NECPAL positive or NECPAL negative according to predefined criteria.

The study will estimate the proportion of patients identified as NECPAL positive, describe their clinical characteristics, and analyze whether they are receiving palliative care. Secondary objectives include comparing clinical variables, comorbidity indices, and mortality between NECPAL-positive and NECPAL-negative patients over follow-up.

The results of this study will provide information on the prevalence of palliative care needs among patients with advanced chronic diseases and support early identification strategies in hospital settings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older. * Hospitalized patients admitted for an acute medical condition or patients attending a day hospital. * Presence of at least one advanced chronic oncological or non-oncological disease. * Ability to provide informed consent or availability of a legally authorized representative to provide consent. Exclusion Criteria: * Patients in the last days of life at the time of assessment. * Patients who die during the acute hospitalization process. * Patients with end-stage organ failure who are listed for organ transplantation. * Patients with severe psychiatric disease that interferes with study participation. * Patients previously included in the study during a prior hospital admission. * Patients for whom outpatient follow-up cannot be ensured.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Hospital Universitario Infanta Leonor Madrid Madrid
Hospital Universitario Infanta Leonor Madrid Madrid

More Infanta Leonor University Hospital trials in Spain

AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images Active, not recruiting
External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients Recruiting
Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies. Recruiting
Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients Recruiting

Other trials for the same condition

Physiotherapy in Pediatric Oncology Starting soon
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors Active, not recruiting
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma Active, not recruiting
SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New Starting soon
Community-Based Exercise Oncology: Real-World Evidence of High Adherence, Improved Quality of Life and Cost-Effectiveness Across the Cancer Continuum Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07387224 on ClinicalTrials.gov ↗ ← All trials in Spain